HIGHLIGHTS
- who: Joanna Bogacka and collaborators from the Department of Pain Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street, Krakow, Poland have published the research: CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy, in the Journal: (JOURNAL)
- how: The data found that each of these chemokines played an important role in nociceptive processes which suggests that CCR4 blockade has therapeutic utility. This result is important from a clinical point of view because patients with diabetes_mellitus often experience a decline in locomotor performance with the development of neuropathic pain . These . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.